The integration of artificial intelligence (AI) and machine learning (ML) into health care and biomedicine is transforming the industry by enhancing diagnostics, treatment planning, and […]
FDA Shares Approach to Regulating AI: What Life Science Companies Need to Know Read More »
NIST recently released the Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile (NIST-AI-600-1). This framework was developed to assist organizations in identifying the specific
FDA’s Troy Tazbaz, Director, and John Nicol, PhD, Digital Health Specialist at the FDA’s Digital Health Center of Excellence (DHCoE), recently proposed “A Lifecycle Management
FDA Proposes AI Lifecycle Management Framework Read More »
AsssurX Briefing Note Axendia was recently briefed by Stephanie Ojeda, Director of Product Management, Life Sciences and Manufacturing and Sal Lucido, Executive VP and Co-Founder
Appian Briefing Note Axendia was recently briefed by Evi Cohen, Global Industry Leader, Life Sciences, along with Nicholas Costa, Analyst Relations Manager; Andres Carrillo, Director,
Empowering Life Sciences with an AI-Powered Unified Automation Platform Read More »
Nuvolo Briefing Note Axendia was recently briefed by Ethan Smith, General Manager, Life Sciences at Nuvolo, which was acquired by Trane Technologies in November 2023.
Strategic Synergy: Nuvolo, Now Part of Trane Technologies Read More »
The Good, The Bad and The Ugly In the rapidly evolving landscape of life sciences, generative AI (GEN AI) stands as a beacon of innovation,
The State of Generative AI In Life Sciences: New Market Research Read More »
How Will It Affect You? The FDA has released a paper through its medical product centers to reaffirm its commitment to the responsible and ethical
FDA on Artificial Intelligence Across the Product Lifecycle Read More »
AspenTech Inmation Briefing Note Axendia was recently briefed by the Pharmaceutical and DataWorks Business Units at Aspen Technology, Inc., (AspenTech) on the acquisition of Inmation™,
Data is the New Battlefied Read More »
Comments Due by October 30, 2023 On September 19, 2023 FDA released its IT Strategy for FY 2024 – 2027. In 2009, Axendia completed a
FDA Announces IT Strategy for Fiscal Years 2024 to 2027 Read More »
42Q Briefing Note Axendia was recently briefed by the leadership team at 42Q, a product division of Sanmina Corporation. With over thirty years of experience,
Simplifying the Digital Factory with Multi-Tenant Cloud MES Read More »
Dot Compliance Briefing Note Axendia was recently briefed by the executive team at Dot Compliance, on its newly released, ready-to-use AI-powered QMS. Headquartered in Phoenix,
Say Hello to Dottie: Combining Quality, Compliance and Production Optimization with AI Read More »
